BiotechTube
Home/Merck KGaA/Peter Guenter
PG

Peter Guenter

Member of the Executive Board, CEO Healthcare

Merck KGaA

Roles

Member of the Executive Board, CEO HealthcareatMerck KGaA
Board Director (nominated)atIpsen

Therapeutic Areas

OncologyNeurologyImmunology

Merck KGaA Pipeline

DrugIndicationPhase
Bavencio (avelumab) + Axitinib1st-line Renal Cell CarcinomaApproved
Bavencio (avelumab)Maintenance Urothelial CarcinomaApproved
EvobrutinibRelapsing Multiple SclerosisPhase 3
XevinapantLocally Advanced Head and Neck Squamous Cell CarcinomaPhase 3
M9140Colorectal CancerPhase 1/2
M1231NSCLC, Esophageal Squamous Cell CarcinomaPhase 1
M8891Advanced Solid TumorsPhase 1/2

Leadership Team at Merck KGaA

BG
Belén Garijo
Chair of the Executive Board and CEO
MH
Matthias Heinzel
Member of the Executive Board, CEO Life Science
KB
Kai Beckmann
Member of the Executive Board, CEO Electronics, Chief Administration Officer
MK
Marcus Kuhnert
Member of the Executive Board, Chief Financial Officer
View full Merck KGaA profile